1. BASELINE CIRCULATING CELL‐FREE DNA LOAD IS RELATED TO, BUT ADDS PROGNOSTIC VALUE TO METABOLIC TUMOR BURDEN MEASURED BY FDG PET/CT IN FOLLICULAR LYMPHOMA. (June 2017) Authors: Delfau‐Larue, M.H.; Benmaad, I.; Robert, P.; Hamdane, S.; Nel, I.; Dupuis, J.; Haioun, C.; Berriolo Riedinger, A.; Casasnovas, R.O.; Itti, E. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Frequency and prognostic value of cutaneous molecular residual disease in mycosis fungoides: a prospective multicentre trial of the Cutaneous Lymphoma French Study Group. (1st October 2015) Authors: Hurabielle, C.; Ingen‐Housz‐Oro, S.; Ortonne, N.; Cornillet‐Lefèbvre, P.; Merah, A.; D'Incan, M.; Joly, P.; Franck, N.; Estève, E.; Maubec, E.; Grange, F.; Machet, L.; Laroche, L.; Barete, S.; Dalac, S.; Mortier, L.; Michel, C.; Quereux, G.; Saiag, P.; Ram‐Wolff, C. Journal: British journal of dermatology Issue: Volume 173:Number 4(2015:Oct.) Page Start: 1015 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Frequency and prognostic value of cutaneous molecular residual disease in mycosis fungoides: a prospective multicentre trial of the Cutaneous Lymphoma French Study Group. (5th October 2015) Authors: Hurabielle, C.; Ingen‐Housz‐Oro, S.; Ortonne, N.; Cornillet‐Lefèbvre, P.; Merah, A.; D'Incan, M.; Joly, P.; Franck, N.; Estève, E.; Maubec, E.; Grange, F.; Machet, L.; Laroche, L.; Barete, S.; Dalac, S.; Mortier, L.; Michel, C.; Quereux, G.; Saiag, P.; Ram‐Wolff, C. Journal: British journal of dermatology Issue: Volume 173:Number 4(2015:Oct.) Page Start: 1015 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. LOW NK CELL COUNT AT DIAGNOSIS IS ASSOCIATED WITH SHORTER PFS IN ELDERLY PATIENTS WITH DLBCL TREATED WITH RCHOP AND RANDOMIZED FOR LENALIDOMIDE MAINTENANCE: a LYSA STUDY. (June 2017) Authors: Delfau‐Larue, M.H.; Beldi‐Ferchiou, A.; Jais, J.; Godard, N.; Salles, G.A.; Casasnovas, R.; Tilly, H.; Fruchart, C.; Morschhauser, F.; Haioun, C.; Lazarovici, J.; Perrot, A.; Sebban, C.; Bouabdallah, R.; Gonzalez, H.; Corront, B.; Oberic, L.; Briere, J.; Gaulard, P.; Coiffier, B. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. RITUXIMAB PLUS LENALIDOMIDE IS AS EFFECTIVE AS IMMUNOCHEMOTHERAPY IN THE ERADICATION OF MOLECULAR DISEASE IN UNTREATED FOLLICULAR LYMPHOMA: RELEVANCE LYSA ANCILLARY STUDY. (12th June 2019) Authors: Delfau‐Larue, M.H.; Boulland, M.L.; Feugier, P.; Maisonneuve, H.; Casasnovas, O.; Haioun, C.; Pica, G.M.; Lamy de la Chapelle, T.; Ysebaert, L.; Tilly, H.; Eisenmann, J.C.; Le Gouil, S.; Ribrag, V.; Jardel, H.; Glaisner, S.; Cartron, G.; Salles, G.; Xerri, L.; Fest, T.; Morschhauser, F. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SERUM 2‐HYDROXYGLUTARATE, A PREDICTIVE BIOMARKER OF THE PRESENCE OF IDH2 MUTATIONS IN AITL PATIENTS. (June 2017) Authors: Broutin, S.; Dupuy, A.; Koscielny, S.; Fataccioli, V.; Lemonnier, F.; de Leval, L.; Robe, C.; Pujals, A.; Safar, V.; Delarue, R.; Delfau‐Larue, M.H.; Ribrag, V.; Haioun, C.; Gaulard, P.; Paci, A. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 392 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗